NCT04523987View on ClinicalTrials.gov

A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 22, 2019

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Metastatic Pancreatic Ductal Adenocarcinoma
Interventions
DRUG

Ciprofloxacin

Subjects enrolled will be administered oral ciprofloxacin twice a day throughout the course of each 28-day cycle of gemcitabine and nab-paclitaxel chemotherapy.

Trial Locations (1)

Unknown

National University Hospital, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER